The 13th Munich Cancer Retreat (MCR13), held on May 19-20, 2026 at the Evangelische Akademie Tutzing, once again brought together scientists, clinicians, physician scientists, and early career…
Scientists from the German Cancer Research Center (DKFZ), the HI-STEM Stem Cell Institute and the German Cancer Consortium (DKTK) have deciphered a key mechanism that contributes to treatment failure…
The Berlin DKTK Community Meeting took place on February 27, 2026 at the Rahel Hirsch Center for translational medicine in Berlin-Mitte. Approximately 120 scientists and doctors came together to…
In aggressive lymphomas, inflammatory messengers reprogram the “conductors” of the immune system, causing lymph nodes structure to collapse. A team led by DKTK scientist Simon Haas describes in…
The University Children's Hospital Zurich and the Thomas and Doris Ammann Foundation have awarded the Thomas and Doris Ammann Prize to Stefan Pfister, Director of the Hopp Children's Cancer Center…
HARPOON is organized by the DKFZ/NCT/DKTK MASTER-team of the NCT Heidelberg and is intended to provide a platform for exchange and networking and to foster interaction between the One NCT, the DKTK,…
What happens in the brain after radiotherapy? Why do many brain tumor patients still struggle with undesirable consequences of therapy, even years after recovery? Are there ways to prevent these and…
Metastatic prostate cancer is currently associated with high morbidity and mortality rates. In addition, patients respond very differently to standard treatments such as hormone therapy or radiation…
On January 27, 2026, researchers from all eight DKTK partner sites convened at the BDC Meeting Space in Heidelberg for the Scientific Community Meeting within DKTK Pillar 2 “Diagnostic Innovations &…
The DZG Innovation Fund (DZGIF) is a joint research funding program of the German Centers for Health Research (DZG). Each call for proposals has a specific research topic. To be eligible for funding,…
Turning research results into innovations: that is the stated goal of the European Research Council’s (ERC) Proof of Concept Grants. With CHECKVIR, a project that builds on ERC-funded research is…
Dr. Sebastian Scheich of University Hospital Frankfurt will receive around €2 million over the next six years through the Emmy Noether Program for his research into an aggressive form of lymph node…
Why does pancreatic cancer form synapses? This is the question that Prof. Ekin Demir aims to answer together with his research team at TUM University Hospital Rechts der Isar. He will now be able to…
Jens Puschhof, junior research group leader at the German Cancer Research Center (DKFZ), receives the 2026 Research Award from the Peter and Traudl Engelhorn Foundation. The foundation honors the…
Pancreatic cancer is one of the deadliest types of tumors. A team at the Technical University of Munich (TUM) and the German Cancer Consortium (DKTK), partner site Munich, has discovered that…
At the DKTK partner site Munich, the Wilko Weichert Grant is awarded annually for an interdisciplinary, early-career-supporting, and cross-LMU/TUM project. In 2025, the project “Investigation of…
Researchers from Charité – Universitätsmedizin Berlin, the University Medical Center Göttingen and the German Cancer Consortium (DKTK) have discovered a potential new approach to the treatment of…
On October 6, 2025, around 90 researchers of the German Cancer Consortium (DKTK) from all eight partner sites gathered at the BDC Meeting Space in Heidelberg for the DKTK Scientific Community Meeting…
On October 7, 2025, around 80 participants from academia and industry came together in Heidelberg for the “Science meets Industry Day”, jointly organized by the German Cancer Consortium (DKTK), the…
Neuroblastoma, a cancer mainly affecting children, is often difficult to treat. Researchers at Charité – Universitätsmedizin Berlin and the Max Delbrück Center now report a potential reason treatment…